These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
975 related articles for article (PubMed ID: 14674897)
1. Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer). Katalinic A; Kunze U; Schäfer T Br J Dermatol; 2003 Dec; 149(6):1200-6. PubMed ID: 14674897 [TBL] [Abstract][Full Text] [Related]
2. Incidence trends of nonmelanoma skin cancer in Germany from 1998 to 2010. Rudolph C; Schnoor M; Eisemann N; Katalinic A J Dtsch Dermatol Ges; 2015 Aug; 13(8):788-97. PubMed ID: 26213814 [TBL] [Abstract][Full Text] [Related]
3. Epidemiology of skin cancer in the German population: impact of socioeconomic and geographic factors. Augustin J; Kis A; Sorbe C; Schäfer I; Augustin M J Eur Acad Dermatol Venereol; 2018 Nov; 32(11):1906-1913. PubMed ID: 29633375 [TBL] [Abstract][Full Text] [Related]
4. Italian cancer figures--Report 2015: The burden of rare cancers in Italy. ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748 [TBL] [Abstract][Full Text] [Related]
5. Does skin cancer screening save lives? A detailed analysis of mortality time trends in Schleswig-Holstein and Germany. Stang A; Jöckel KH Cancer; 2016 Feb; 122(3):432-7. PubMed ID: 26480048 [TBL] [Abstract][Full Text] [Related]
6. Incidence, Mortality, and Trends of Nonmelanoma Skin Cancer in Germany. Leiter U; Keim U; Eigentler T; Katalinic A; Holleczek B; Martus P; Garbe C J Invest Dermatol; 2017 Sep; 137(9):1860-1867. PubMed ID: 28487088 [TBL] [Abstract][Full Text] [Related]
7. Non-melanoma skin cancer incidence and impact of skin cancer screening on incidence. Eisemann N; Waldmann A; Geller AC; Weinstock MA; Volkmer B; Greinert R; Breitbart EW; Katalinic A J Invest Dermatol; 2014 Jan; 134(1):43-50. PubMed ID: 23877569 [TBL] [Abstract][Full Text] [Related]
8. Epidemiology of skin cancer. Leiter U; Eigentler T; Garbe C Adv Exp Med Biol; 2014; 810():120-40. PubMed ID: 25207363 [TBL] [Abstract][Full Text] [Related]
9. Non-melanoma skin cancer: ten years of cancer-registry-based surveillance. Kaldor J; Shugg D; Young B; Dwyer T; Wang YG Int J Cancer; 1993 Apr; 53(6):886-91. PubMed ID: 8473047 [TBL] [Abstract][Full Text] [Related]
10. Skin cancer (Basal cell carcinoma, squamous cell carcinoma, and malignant melanoma): new cases, treatment practice, and health care costs in new brunswick, Canada, 2002-2010. Pilgrim W; Hayes R; Hanson DW; Zhang B; Boudreau B; Leonfellner S J Cutan Med Surg; 2014 Oct; 18(5):320-31. PubMed ID: 25186993 [TBL] [Abstract][Full Text] [Related]
11. Skin Cancer Screening in Germany. Documenting Melanoma Incidence and Mortality From 2008 to 2013. Katalinic A; Eisemann N; Waldmann A Dtsch Arztebl Int; 2015 Sep; 112(38):629-34. PubMed ID: 26429634 [TBL] [Abstract][Full Text] [Related]
12. Malignant melanoma and nonmelanoma skin cancers in Northrhine-Westphalia, Germany: a patient- vs. diagnosis-based incidence approach. Stang A; Ziegler S; Büchner U; Ziegler B; Jöckel KH; Ziegler V Int J Dermatol; 2007 Jun; 46(6):564-70. PubMed ID: 17550552 [TBL] [Abstract][Full Text] [Related]
13. Epidemiology of cutaneous melanoma and keratinocyte cancer in white populations 1943-2036. Garbe C; Keim U; Gandini S; Amaral T; Katalinic A; Hollezcek B; Martus P; Flatz L; Leiter U; Whiteman D Eur J Cancer; 2021 Jul; 152():18-25. PubMed ID: 34062483 [TBL] [Abstract][Full Text] [Related]
14. Trends in basal cell carcinoma, squamous cell carcinoma, and melanoma of the skin from 1973 through 1987. Gallagher RP; Ma B; McLean DI; Yang CP; Ho V; Carruthers JA; Warshawski LM J Am Acad Dermatol; 1990 Sep; 23(3 Pt 1):413-21. PubMed ID: 2212139 [TBL] [Abstract][Full Text] [Related]
15. Skin cancer mortality in Germany before and after the post-communist transition. Stang A; Lampert T; Uhlemann T; Trocchi P Int J Dermatol; 2009 Apr; 48(4):363-70. PubMed ID: 19335420 [TBL] [Abstract][Full Text] [Related]
16. Italian cancer figures, report 2012: Cancer in children and adolescents. ; ; Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445 [TBL] [Abstract][Full Text] [Related]
17. Skin cancer trends in Northern Ireland and consequences for provision of dermatology services. Hoey SE; Devereux CE; Murray L; Catney D; Gavin A; Kumar S; Donnelly D; Dolan OM Br J Dermatol; 2007 Jun; 156(6):1301-7. PubMed ID: 17535230 [TBL] [Abstract][Full Text] [Related]
18. Do cancer registries play a role in determining the incidence of non-melanoma skin cancers? Anselmo Lima C; Sampaio Lima M; Maria Da Silva A; Prado Nunes MA; Macedo Lima MM; Oliveira Santos M; Lyra D; Kleber Alves C Eur J Dermatol; 2018 Apr; 28(2):169-176. PubMed ID: 29619990 [TBL] [Abstract][Full Text] [Related]
19. Increasing skin cancer incidence in young, affluent, urban populations: a challenge for prevention. Deady S; Sharp L; Comber H Br J Dermatol; 2014 Aug; 171(2):324-31. PubMed ID: 24666396 [TBL] [Abstract][Full Text] [Related]
20. Skin cancer in children and young adults: 28 years' experience from the Northern Region Young Person's Malignant Disease Registry, UK. Pearce MS; Parker L; Cotterill SJ; Gordon PM; Craft AW Melanoma Res; 2003 Aug; 13(4):421-6. PubMed ID: 12883370 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]